Piedmont Cancer Institute
1 clinical trials · Sponsor
◉ Watch Piedmont Cancer Institute
| Record | Firm | Date |
|---|---|---|
| High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer (NCT03797443) | Piedmont Cancer Institute | 2019-01-01 |
Track Piedmont Cancer Institute automatically
Every clearance here is in the API, with alerts when new ones post.